Home » U.S. Generics Must Expand 'Value Chain' to Compete Globally
U.S. Generics Must Expand 'Value Chain' to Compete Globally
March 29, 2006
U.S. generic drug firms should diversify to include more segments of the pharmaceutical manufacturing and marketing process if
they hope to compete globally, said one pharmaceutical finance expert at a recent industry conference.